Tower Research Capital (TRC)’s Whitehawk Therapeutics WHWK Stock Holding History
Bought
Maintained
Sold
Other funds holding WHWK
YF
SL
Tower Research Capital (TRC)'s WHWK Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Whitehawk Therapeutics (WHWK) stake by 5% in Q3 2026, buying an estimated $539 and bringing the position to 2,683 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4304.
Tower Research Capital (TRC) first reported a position in WHWK in Q2 2018 and has held it in 25 quarters since. The position peaked at $91K in Q3 2022. 91 funds tracked by Wall St. Rank hold WHWK as of Q3 2026.
- Tower Research Capital (TRC) held 2,683 shares of Whitehawk Therapeutics worth $10.1K as of Q3 2026.
- Tower Research Capital (TRC) bought 128 Whitehawk Therapeutics shares in Q3 2026, an estimated $539.
- Whitehawk Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4304 holding.
- Tower Research Capital (TRC) first reported a position in Whitehawk Therapeutics in Q2 2018 and has held it in 25 quarters since.
- Tower Research Capital (TRC)'s Whitehawk Therapeutics position peaked at $91K in Q3 2022.
- 91 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.